|
People
The highly qualified, entrepreneurial spirited and motivated team at ESBATech encourage a creative and innovative culture, dedicated to developing ideas and finding solutions to significant therapeutic challenges in the treatment of ophthalmic diseases.
The Company has currently more than 60 employees. The majority hold an MD, Ph.D. or a Master of Science degree in the fields of Molecular Biology, Biochemistry, Immunology or Medicine.
| Senior Management |
|
|
| Dominik Escher, Ph.D. | Managing Director and VP R&D | >> CV
|
| Peter Lichtlen, MD/Ph.D. | Head Clinical Research & Development | >> CV
|
| Anne Schmidt, Ph.D. | Head Project Management | >> CV
|
| Peter Steiner, Ph.D. | Head Production & Processes | >> CV
|
| David Urech, Ph.D. | Head Research & Preclinical Development | >> CV
|
| Key Personnel |
|
|
| Jürgen E. Bader, Ph.D. | Pharmaceutical Production Manager |
|
| Ulrich Bauer | Head Fermentation and Standard Productions |
|
| Leo Borras | Head Protein Engineering |
|
| Esther Furrer, Ph.D. | Head in vivo Biology |
|
| John Grimshaw, Ph.D. | Head Structural Biophysics and Formulation |
|
| Tea Gunde, Ph.D. | Head Molecular Biology/Assay Development |
|
| Colin Hughson, MD | Drug Safety Officer |
|
| Valérie Hulmann, Ph.D. | Head Screening Technology |
|
| Markus Jauslin | Head of Accounting |
|
| Sushanta Mallick, Ph.D. | Head Clinical Trial Management |
|
| Sebastian Meyer, Ph.D. | Head Downstream Processing & Analytics |
|
| Oliver Middendorp, Ph.D. | Head Alliance Management |
|
| Hermann Schulze, Ph.D. |
Head Regulatory Affairs and Quality Assurance |
|
| Konstantin von Schulthess | Manager Finance |
|
|
